MAPT and Alzheimer disease: While the BIN1 risk allele has been identified as the second most prevalent susceptibility gene in GWAS studies, there are conflicting results presented in the literature on BIN1 protein expression in Alzheimer’s disease and tau and B-amyloid pathology (Andrew et al., 2019).